Correlation of serum vascular adhesion protein-1 with airflow limitation and quality of life in stable chronic obstructive pulmonary disease
Respiratory Medicine Oct 19, 2017
Amani M, et al. - This study assessed stable chronic obstructive pulmonary disease (COPD) patients for serum vascular adhesion protein-1 (VAP-1) level and its correlation with airflow limitation and health-related quality of life using the COPD Assessment Test (CAT). Findings demonstrated that an increase in serum VAP-1 level was obvious with an increasing severity of obstruction. Furthermore, this increase was found to be related to a reduced quality of life and increased severity of hypoxia. Overall, it was indicated that inhibiting serum VAP-1 level in this patient population may be a useful management strategy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries